Pentagon rescinds new testosterone screening policy without explanation

The United States Department of Defense has abruptly retracted a newly introduced clinical guidance directive that mandated testosterone evaluations for military personnel.

Originally announced during the summer by Defense Secretary Pete Hegseth as an initiative to optimize physical capabilities and promote longevity among service members, the program was designed to screen male troops over the age of thirty and evaluate female troops for hormonal imbalances. However, just one day after its formal publication, the Pentagon removed the guidelines and associated statements from its official channels. Department representatives later clarified that the retraction was a temporary measure intended to facilitate updates, though they declined to provide details on what specific changes were being made or why the document was recalled so quickly.\n\nIn the wake of the initial policy announcement, numerous medical specialists voiced significant concerns regarding the scientific validity and long-term safety of implementing widespread hormonal screenings. Prominent healthcare organizations, including the Endocrine Society and the American Urological Association, actively advise against routine testosterone testing for individuals without specific clinical indicators. Independent medical experts warned that such sweeping public health measures in the military could lead to unnecessary evaluations, diagnostic errors, and improper prescriptions of hormone replacement therapies. These treatments are associated with notable health risks, including cardiovascular issues, sleep apnea, fertility reduction, elevated red blood cell counts, and an increased likelihood of developing certain cancers.